NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000055584

Registered date:24/09/2024

The outcome of chemoradiotherapy for NSCLC - EGFR mutant vs wild-type -

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiednon small cell lung cancer
Date of first enrollment2024/10/01
Target sample size
Countries of recruitmentJapan
Study typeOthers,meta-analysis etc
Intervention(s)

Outcome(s)

Primary Outcomeprogression-free survival and overall survival
Secondary Outcomepost-progression survival, patterns of disease progression

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaExclusion criteria were: (i) non-English publications; (ii) studies including patients receiving targeted therapy or immunotherapy; (iii) studies involving radiotherapy alone.

Related Information

Contact

public contact
Name Satoru Ochiai
Address Ise Red Cross Hospital 1-471-2 Funae, Ise City, Mie Prefecture, Japan Japan 516-8512
Telephone 0596-28-2171
E-mail sochiamn@gmail.com
Affiliation JAPANESE RED CROSS ISE HOSPITAL Department of Radiation Oncology
scientific contact
Name Satoru Ochiai
Address Ise Red Cross Hospital 1-471-2 Funae, Ise City, Mie Prefecture, Japan Japan
Telephone 0596-28-2171
E-mail sochiamn@gmail.com
Affiliation JAPANESE RED CROSS ISE HOSPITAL Department of Radiation Oncology